Lantern Pharma (LTRN) Shares Issued (2020 - 2024)

Lantern Pharma's (LTRN) quarterly Shares Issued came in at $1.3 million in Q3 2024, up 39.04% on a QoQ basis from $916670.0 in Q2 2024.

Lantern Pharma (LTRN) Shares Issued (2020 - 2024) Analysis & Trends

Lantern Pharma (LTRN) has 4 years of Shares Issued data on file, last reported at $1.3 million in Q3 2024.

Quarterly Shares Issued changed N/A year-over-year to $1.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.3 million (changed N/A YoY) and the FY2021 annual result came in at $687438.0, up 12.58% from the prior year.
Shares Issued advanced to $1.3 million in Q3 2024, from $916670.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $1.3 million in Q3 2024 to a low of $610633.0 in Q4 2020.
A 4-year average of $922622.6 and a median of $916670.0 in 2024 frame the typical range for Shares Issued.
The widest YoY moves for Shares Issued: up 12.58% in 2021, down 12.58% in 2021.
Tracing LTRN's Shares Issued over 4 years: stood at $610633.0 in 2020, then advanced by 12.58% to $687438.0 in 2021, then soared by 45.61% to $1.0 million in 2022, then advanced by 27.33% to $1.3 million in 2024.
The last three Shares Issued figures came in at $1.3 million (Q3 2024), $916670.0 (Q2 2024), and $1.1 million (Q1 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Lantern Pharma	26.05 Mn	26.05 Mn	-	-

Download Data